International Circulation: High blood pressure is a leading risk factor for cardiovascular morbidity and mortality so the proper management of hypertension is very important to improve the prognosis. How do you think we can diminish the gap between the guidelines and clinical practice?
《国际循环》：高血压是心血管事件最主要的危险因素，恰当的治疗对改善预后非常重要，您认为应该如何缩短指南与临床实践之间的差距？

Prof Nilsson: I think it is so important to find simple， useful and practical ways - to increase knowledge and teaching， to use group sessions. Traditionally， at least in Western medicine， we used to see patients one by one， but in other cultures they are more used to seeing whole families or groups of patients. I think we should learn from that - to open up the door and have group sessions and increase the ambition to do more. Secondly， I think that the poly-pill issue is worthy of further investigations. So far there has been one publication based on a feasibility study in India (Lancet 2009) using the poly-pill just to find the appropriate dosage of the pharmacological substance. However， right now there is an ongoing larger trial in New Zealand which I think we should learn from that whether it’s feasible， whether it’s practical， whether it pays off. I think that one day we could possibly be using some kind of poly-pill， not for everybody， but for some risk patients， and I hope that we will see the day when we are less interested in risk factors and risk markers and go for target organ damage to find simple ways to evaluate the impact of risk factors. I am talking about arterial stiffness. I am talking about left ventricular hypertroph